Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination

Leuk Lymphoma. 2022 Oct;63(10):2489-2493. doi: 10.1080/10428194.2022.2074989. Epub 2022 May 14.

Authors

Lara Howells¹, Wei Yee Chan¹, Emilie Sanchez², Jacqueline Horder¹, Fiona Newrick¹, Jotham Marfil¹, Annabel McMillan¹, Brendan Wisniowski¹, Shameem Mahmood¹, Xenofon Papanikolaou¹, Lydia Lee^{1

3}, Ashutosh Wechalekar¹, Rakesh Popat¹, Jonathan Sive¹, Charalampia Kyriakou¹, Ke Xu¹, Eleni Nastouli², Kwee L Yong^{1

3}, Neil Rabin¹

Affiliations

¹ Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
² Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, UK.
³ Research Department of Haematology, UCL Cancer Institute, London, UK.

PMID: 35570744
DOI: 10.1080/10428194.2022.2074989

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral
COVID-19 Vaccines
COVID-19* / prevention & control
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Immunity, Humoral*
Plasma Cells
Vaccination

Substances

Antibodies, Viral
COVID-19 Vaccines

Grants and funding

MR/S001883/1/MRC_/Medical Research Council/United Kingdom